The Global Endocrinology Drugs Market is expected to grow by $36551.24 mn from 2023-2027, accelerating at a CAGR of 7.82% during the forecast period


Global Endocrinology Drugs Market 2023-2027 The analyst has been monitoring the endocrinology drugs market and is poised to grow by $36551. 24 mn from 2023-2027, accelerating at a CAGR of 7.

New York, Nov. 30, 2022 (GLOBE NEWSWIRE) -- announces the release of the report "Global Endocrinology Drugs Market 2023-2027" -
82% during the forecast period. Our report on the endocrinology drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by an increase in the incidence of endocrine disorders, a promising pipeline for endocrinology, and research in novel dosage formulations and drug delivery systems.

The endocrinology drugs market is segmented as below:
By Therapy Area
• Diabetes drugs
• Thyroid hormone disorders
• Others

By Distribution Channel
• Hospital pharmacies
• Retail pharmacies
• Online pharmacies

By Geographical Landscape
• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the association between obesity and endocrine disorders as one of the prime reasons driving the endocrinology drugs market growth during the next few years. Also, the use of biosimilars for endocrine disorders and the growing geriatric population will lead to sizable demand in the market.

The analyst presents a detailed picture of the market through the study, synthesis, and summation of data from multiple sources through an analysis of key parameters. Our report on the endocrinology drugs market covers the following areas:
• Endocrinology drugs market sizing
• Endocrinology drugs market forecast
• Endocrinology drugs market industry analysis

This robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading endocrinology drugs market vendors that include Abbott Laboratories, Acerus Pharmaceuticals Corp., Ascendis Pharma AS, Bayer AG, Beta Cell NV, Biocon Ltd., Eli Lilly and Co., Endo International Plc, F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, Hanmi Pharm Co. Ltd., Ipsen Pharma, Merck and Co. Inc., Novartis AG, Novo Nordisk AS, Oramed Pharmaceuticals Inc., Pfizer Inc., Sanofi SA, Takeda Pharmaceutical Co. Ltd., and VeroScience LLC. Also, the endocrinology drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The analyst presents a detailed picture of the market through the study, synthesis, and summation of data from multiple sources through an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio’s market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Read the full report:

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.


CONTACT: Clare: US: (339)-368-6001 Intl: +1 339-368-6001